These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17496491)

  • 21. The effect of the public or private status of health care facility in acute coronary syndrome: data from Thai ACS Registry.
    Hutayanon P; Sarakarn P; Buakhamsri A; Boonsom W; Yamwong S
    J Med Assoc Thai; 2007 Oct; 90 Suppl 1():98-108. PubMed ID: 18431892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics and early mortality of patients undergoing coronary artery bypass grafting compared to percutaneous coronary intervention: insights from the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and the Melbourne Interventional Group (MIG) Registries.
    Yan BP; Clark DJ; Buxton B; Ajani AE; Smith JA; Duffy SJ; Shardey GC; Skillington PD; Farouque O; Yii M; Yap CH; Andrianopoulos N; Brennan A; Dinh D; Reid CM; ;
    Heart Lung Circ; 2009 Jun; 18(3):184-90. PubMed ID: 19268632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-induced nephropathy following percutaneous coronary intervention: case report.
    Sousa CS; Pedro MM; Pinto FJ
    Rev Port Cardiol; 2009 Mar; 28(3):309-21. PubMed ID: 19480314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mayo Clinic Risk Score for percutaneous coronary intervention predicts in-hospital mortality in patients undergoing coronary artery bypass graft surgery.
    Singh M; Gersh BJ; Li S; Rumsfeld JS; Spertus JA; O'Brien SM; Suri RM; Peterson ED
    Circulation; 2008 Jan; 117(3):356-62. PubMed ID: 18172033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iloprost prevents contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Spargias K; Adreanides E; Demerouti E; Gkouziouta A; Manginas A; Pavlides G; Voudris V; Cokkinos DV
    Circulation; 2009 Nov; 120(18):1793-9. PubMed ID: 19841299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic-guided percutaneous coronary intervention enabled by two-dimensional guidewire steering and three-dimensional virtual angioscopy: initial experiences in daily clinical practice.
    Schneider MA; Hoch FV; Neuser H; Brunn J; Koller ML; Gietzen F; Schamberger R; Kerber S; Schumacher B
    J Interv Cardiol; 2008 Apr; 21(2):158-66. PubMed ID: 18248356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Premedication for cardiac catheterization and percutaneous coronary intervention: does it increase vascular access site complications?
    Woodhead J; Harding SA; Simmonds M; Dee S; McBride-Henry K
    J Cardiovasc Nurs; 2007; 22(6):466-71. PubMed ID: 18090187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Percutaneous revascularization in patients with previous coronary artery bypass graft surgery. Immediate and 1-year clinical outcomes.
    Tejada JG; Velazquez M; Hernandez F; Albarran A; Gomez I; Rodriguez S; Andreu J; Tascon J
    Int J Cardiol; 2009 May; 134(2):201-6. PubMed ID: 18508141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
    Maioli M; Toso A; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Bellandi F
    J Am Coll Cardiol; 2008 Aug; 52(8):599-604. PubMed ID: 18702961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term clinical outcome of coronary artery stenting or coronary artery bypass grafting in patients with multiple-vessel disease.
    Kohsaka S; Goto M; Virani S; Lee VV; Aoki N; Elayda MA; Reul RM; Wilson JM
    J Thorac Cardiovasc Surg; 2008 Aug; 136(2):500-6. PubMed ID: 18692664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention.
    Patti G; Nusca A; Chello M; Pasceri V; D'Ambrosio A; Vetrovec GW; Di Sciascio G
    Am J Cardiol; 2008 Feb; 101(3):279-85. PubMed ID: 18237585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors affecting post minimally invasive direct coronary artery bypass grafting incidence of myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting and mortality of cardiac origin.
    Kofidis T; Gerd Paeschke H; Lichtenberg A; Emmert M; Woitek F; Didilis V; Haverich A; Klima U
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):49-53. PubMed ID: 18786942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xinwei J; Xianghua F; Jing Z; Xinshun G; Ling X; Weize F; Guozhen H; Yunfa J; Weili W; Shiqiang L
    Am J Cardiol; 2009 Aug; 104(4):519-24. PubMed ID: 19660605
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term mortality in patients unsuitable for surgical revascularization undergoing elective left main coronary artery angioplasty.
    Vignali L; Talanas G; Menozzi A; Cattabiani MA; Solinas E; Aurier E; Ardissino D
    Minerva Cardioangiol; 2008 Feb; 56(1):1-11. PubMed ID: 18432163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contrast-induced nephropathy after percutaneous interventions].
    Peruga JZ; Gieras S; Jezewski T; Krzemińska-Pakuła M
    Kardiol Pol; 2009 Aug; 67(8):902-7. PubMed ID: 19784890
    [No Abstract]   [Full Text] [Related]  

  • 38. [Referral to elective and emergency coronary investigation from a medium-size central hospital].
    Aune E; Otterstad JE; Endresen K
    Tidsskr Nor Laegeforen; 2005 Sep; 125(17):2342-4. PubMed ID: 16151489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and procedural characteristics associated with higher radiation exposure during percutaneous coronary interventions and coronary angiography.
    Delewi R; Hoebers LP; Råmunddal T; Henriques JP; Angerås O; Stewart J; Robertsson L; Wahlin M; Petursson P; Piek JJ; Albertsson P; Matejka G; Omerovic E
    Circ Cardiovasc Interv; 2013 Oct; 6(5):501-6. PubMed ID: 24065442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of coronary angiography on oxidative DNA damage observed in circulating lymphocytes.
    Demirbag R; Yilmaz R; Kocyigit A; Guzel S
    Angiology; 2007; 58(2):141-7. PubMed ID: 17495261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.